Fujifulm’s Aspire Cristalle digital mammography solution received FDA clearance yesterday and includes features promoting patient comfort and image quality.
Aspire Cristalle, a new digital mammography breast imaging solution with innovative and methodical features, by Fujifilm, received U.S. Food and Drug Administration (FDA) 510(k) clearance yesterday.
The Aspire Cristalle uses novel detector engineering called hexagonal close pattern (HCP), a detector pixel design engineered to deliver higher acquisition efficiency, finer detail, higher DQE, higher MTF and lower dose than conventional square pixel arrays, according to a release. “[The design is] engineered to produce brilliant images at low dose,” the release stated.
Fujifilm’s image processing, iAEC automated exposure controls and ISC precisely tuned contrast, also enhances the image quality, according to the release. The processing adapts to the specific characteristics for every breast type and implants, the release said.
Patient comfort was also considered in the new mammography solution. Fujifilm included their patented “Comfort Paddle,” in the Aspire Cristalle, which is designed to ease the discomfort of mammograms, the release said. The paddle boasts soft edges, flexible composition and a 4-way pivot contours to the individual shape of the breast for a more
[[{"type":"media","view_mode":"media_crop","fid":"25470","attributes":{"alt":"Fujifilm Aspire Cristalle","class":"media-image media-image-right","id":"media_crop_1823864043690","media_crop_h":"283","media_crop_image_style":"-1","media_crop_instance":"2326","media_crop_rotate":"0","media_crop_scale_h":"0","media_crop_scale_w":"0","media_crop_w":"137","media_crop_x":"0","media_crop_y":"0","style":"margin: 1px; border-style: solid; line-height: 1.538em; width: 150px; height: 310px; float: right;","title":" ","typeof":"foaf:Image"}}]]
comfortable application of compression for optimal tissue separation, the release stated. Patient grip handles, padding for added stability and comfort, and soft backlighting and graphic mural decals were incorporated for further patient comfort. The system also allows
improved access for wheelchair exams, the release said.
“Aspire Cristalle nicely represents our latest culmination of imaging innovation and attention to every detail in design,” Rob Fabrizio, director of marketing and product development, digital X-ray and women’s health, FUJIFILM Medical Systems USA, Inc., said in a release. “The Aspire Cristalle will deliver brilliant images with gentle dose, while redefining the patient experience through a notably more comfortable exam.”
FDA Clears Updated AI Platform for Digital Breast Tomosynthesis
November 12th 2024Employing advanced deep learning convolutional neural networks, ProFound Detection Version 4.0 reportedly offers a 50 percent improvement in detecting cancer in dense breasts in comparison to the previous version of the software.
Is the Kaiser Score More Effective than BI-RADS for Assessing Contrast-Enhanced Mammography and MRI?
October 14th 2024For women with breast-enhanced masses, Kaiser scoring (KS) demonstrated a 20 percent higher AUC than BI-RADS classification for contrast-enhanced mammography (CEM) and was comparable to KS for breast MRI.
FDA Clears New Features in AI-Powered Mammography Software Suite
October 11th 2024Therapixel’s MammoScreen suite has received 510(k) FDA clearances for a breast density assessment feature and updated software that includes automated pre-reporting, which reportedly expedites reporting of mammography findings.